Drugmakers oppose class certification for pharmacies in US Pravastatin antitrust case
MLex Summary: Glenmark Pharmaceuticals, Lupin Pharmaceuticals, Teva Pharmaceuticals and Zydus Pharmaceuticals opposed indirect resellers’ request for class certification in a US antitrust case over Pravastatin, arguing that their claims are too...To view the full article, register now.
Already a subscriber? Click here to view full article